According to Ascendis Pharma 's latest financial reports and stock price the company's current number of shares outstanding is 56,883,257. At the end of 2024 the company had 56,883,257 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2024 | 56.88 M | 0.57% |
2023 | 56.56 M | 1.31% |
2022 | 55.83 M | 2.18% |
2021 | 54.63 M | 3.65% |
2020 | 52.71 M | 10.77% |
2019 | 47.59 M | 13.61% |
2018 | 41.88 M | 28.46% |
2017 | 32.6 M | 29.42% |
2016 | 25.19 M | 2.69% |
2015 | 24.53 M | 44.88% |
2014 | 16.93 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Akebia Therapeutics AKBA | 188,306,350 | 231.04% | ๐บ๐ธ USA |
Affimed
AFMD | 14,933,933 | -73.75% | ๐ฉ๐ช Germany |
Advaxis ADXS | 4,784,474 | -91.59% | ๐บ๐ธ USA |